146 related articles for article (PubMed ID: 9739955)
1. First "antisense" drug will treat CMV retinitis.
Marwick C
JAMA; 1998 Sep; 280(10):871. PubMed ID: 9739955
[No Abstract] [Full Text] [Related]
2. New CMV retinitis drug approved.
Body Posit; 1998 Oct; 11(10):10. PubMed ID: 11365907
[TBL] [Abstract][Full Text] [Related]
3. Fomivirsen approved for CMV retinitis.
Roehr B
J Int Assoc Physicians AIDS Care; 1998 Oct; 4(10):14-6. PubMed ID: 11365956
[TBL] [Abstract][Full Text] [Related]
4. Fomiversen sodium approved to treat CMV retinitis.
Piascik P
J Am Pharm Assoc (Wash); 1999; 39(1):84-5. PubMed ID: 9990192
[No Abstract] [Full Text] [Related]
5. Fomivirsen approved.
AIDS Patient Care STDS; 1998 Dec; 12(12):943. PubMed ID: 11362071
[No Abstract] [Full Text] [Related]
6. Vitravene--another piece in the mosaic.
Crooke ST
Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):vii-viii. PubMed ID: 9743463
[No Abstract] [Full Text] [Related]
7. Fomivirsen for the treatment of cytomegalovirus retinitis.
Jabs DA; Griffiths PD
Am J Ophthalmol; 2002 Apr; 133(4):552-6. PubMed ID: 11931791
[No Abstract] [Full Text] [Related]
8. New CMV drug won't replace other therapies.
AIDS Alert; 1998 Nov; 13(11):124-6. PubMed ID: 11365968
[TBL] [Abstract][Full Text] [Related]
9. Fomivirsen.
Highleyman L
BETA; 1998 Apr; ():29, 31. PubMed ID: 11365261
[TBL] [Abstract][Full Text] [Related]
10. Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
Orr RM
Curr Opin Mol Ther; 2001 Jun; 3(3):288-94. PubMed ID: 11497353
[TBL] [Abstract][Full Text] [Related]
11. Fomivirsen approved for CMV retinitis: first antisense drug.
AIDS Treat News; 1998 Sep; (302):7. PubMed ID: 11365764
[TBL] [Abstract][Full Text] [Related]
12. FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.
Highleyman L
BETA; 1998 Oct; ():5. PubMed ID: 11365993
[TBL] [Abstract][Full Text] [Related]
13. New treatment options for CMV retinitis in AIDS.
Lalezari JP
Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
[No Abstract] [Full Text] [Related]
14. New drug for CMV retinitis.
AIDS Patient Care; 1995 Oct; 9(5):256. PubMed ID: 11361411
[No Abstract] [Full Text] [Related]
15. Advances in CMV management: fomivirsen (Vitravene) approved.
Proj Inf Perspect; 1998 Dec; (26):7. PubMed ID: 11366499
[TBL] [Abstract][Full Text] [Related]
16. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed.
AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828
[No Abstract] [Full Text] [Related]
17. New drug recommended for treatment of CMV retinitis.
Bray JM
STEP Perspect; 1996; 8(1):8. PubMed ID: 11363593
[TBL] [Abstract][Full Text] [Related]
18. Use of ganciclovir implants for CMV retinitis in an 18-month-old child with AIDS.
Dalton R; Aylward GW; Sharland M
Eye (Lond); 1999; 13 ( Pt 1)():110-2. PubMed ID: 10396395
[No Abstract] [Full Text] [Related]
19. ICAAC: what else is new?
Prescott LM
Posit Aware; 1996; 7(1):10-1. PubMed ID: 11363114
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological abnormalities following intravitreal vitravene (ISIS 2922) in two patients with CMV retinitis.
Zambarakji HJ; Mitchell SM; Lightman S; Holder GE
Br J Ophthalmol; 2001 Sep; 85(9):1142. PubMed ID: 11561556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
